User:Mr. Ibrahem/Cefditoren

Cefditoren, sold under the brand name Spectracef among others, is an antibiotic used to treat strep throat, respiratory tract infections, and skin and skin structure infections. It is effective against both Gram-positive and Gram-negative bacteria. It is taken by mouth with food.

Common side effects include nausea, diarrhea, headache, heart burn, and vaginal yeast infection. Other side effects may include Clostridioides difficile infection and allergic reactions. There is no evidence of harm in pregnancy but such use has not been well studied. It is a third-generation cephalosporin and works by interfering with the bacterial cell wall.

Cefditoren was patented in 1984 and approved for medical use in 1994. It was approved for medical use in the United States in 2001. It is no longer commercially available in the United States as of 2021.